Andreas and Thomas Strüngmann: From Hexal to BioNTech Billionaires
The journey of two identical German twins from a family pharmacy business to building the generics empire Hexal, and then to a bold seed investment that made them key backers of BioNTech's COVID-19 vaccine.
Think & Rich